SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-232843
Filing Date
2009-11-12
Accepted
2009-11-12 16:24:35
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 267580
2 AMENDMENT NO. 1, EFFECTIVE NOVEMBER 11, 2009, TO SUBLEASE AGREEMENT dex101.htm EX-10.1 9031
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7577
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7567
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4294
  Complete submission text file 0001193125-09-232843.txt   297441
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
Myriad Pharmaceuticals, Inc. (Filer) CIK: 0001459450 (see all company filings)

IRS No.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-34275 | Film No.: 091177381
SIC: 2834 Pharmaceutical Preparations